PMID: 11907500Mar 22, 2002Paper

Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily

Journal of the American Academy of Dermatology
Vera H PriceKeith D Kaufman

Abstract

Finasteride, a type II 5alpha-reductase inhibitor, reduces scalp and serum dihydrotestosterone and has been shown to be effective in men with androgenetic alopecia (AGA). The purpose of this study was to determine the effect of finasteride on scalp hair weight in men with AGA. Sixty-six men with AGA received finasteride, 1 mg/d, or placebo in a 48-week study, and 49 men continued in a 48-week extension. Efficacy was assessed by scalp hair weights and hair counts. As expected, hair counts improved with finasteride (net mean percent change +/- SE [95% CI] compared with placebo = 9.2% +/- 2.8% [3.8, 14.6] and 15.4% +/- 3.2% [9.1, 21.7] at 48 and 96 weeks, respectively; P <.01 for both time points), and net improvements in hair weight were greater (25.6% +/- 3.6% [18.5, 32.7] and 35.8% +/- 4.6% [26.7, 44.8] at 48 and 96 weeks, respectively; P <.001 for both time points). Finasteride was generally well tolerated. In this study, finasteride, 1 mg, increased hair weight in men with AGA. Hair weight increased to a larger extent than hair count, implying that factors other than the number of hairs, such as increased growth rate (length) and thickness of hairs, contribute to the beneficial effects of finasteride in treated men.

Citations

Sep 29, 2005·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Matt LeavittCraig Ziering
Aug 14, 2002·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Milos SovakMilan Bucek
Feb 21, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·N P Khumalo, R M Ngwanya
Apr 18, 2006·Seminars in Cutaneous Medicine and Surgery·Marc R Avram
Nov 15, 2011·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Anja BlumeyerUNKNOWN European Dermatology Forum (EDF)
May 26, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·A K GuptaV Piguet
Aug 23, 2002·Clinical and Experimental Dermatology·M D Van Neste
Feb 13, 2003·The Australasian Journal of Dermatology·Alexander J Chamberlain, Rodney P R Dawber
Feb 21, 2004·Skin Pharmacology and Physiology·G E PiérardUNKNOWN EEMCO group (European Expert Group on Efficacy Measurement of Cosmetics and other Topical Products)
Mar 1, 2011·The Journal of Dermatology·Masashi YamazakiRyoji Tsuboi
Mar 27, 2015·Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·A A El-RifaieA E El-Rifaie
Nov 28, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·V KantiU Blume-Peytavi
Jan 21, 2020·Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·Dominique Van Neste
Nov 26, 2009·Pharmaceutical Development and Technology·Yousef JavadzadehAli Nokhodchi
Oct 17, 2020·Clinical, Cosmetic and Investigational Dermatology·Muhammed MajeedKalpesh Shah
Feb 9, 2020·Fertility and Sterility·Abdulmaged M Traish
Sep 17, 2008·Journal of the American Academy of Dermatology·Nicole E Rogers, Marc R Avram

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
Vera H PriceJ Waldstreicher
Journal of the American Academy of Dermatology
J LeydenJ Waldstreicher
Dermatology : International Journal for Clinical and Investigative Dermatology
Ralph M Trüeb, Swiss Trichology Study Group
© 2022 Meta ULC. All rights reserved